JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

Search

DaVita Inc

Închisă

SectorSănătate

107.26 1.31

Rezumat

Modificarea prețului

24h

Curent

Minim

105.46

Maxim

107.55

Indicatori cheie

By Trading Economics

Venit

34M

310M

Vânzări

41M

3.4B

P/E

Medie Sector

11.095

90.422

Marjă de profit

9.051

Angajați

76,000

EBITDA

-53M

637M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+28.92% upside

Dividende

By Dow Jones

Următoarele câștiguri

2 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-1.6B

7.7B

Deschiderea anterioară

105.95

Închiderea anterioară

107.26

Sentimentul știrilor

By Acuity

20%

80%

30 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

DaVita Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 feb. 2025, 19:50 UTC

Principalele dinamici ale pieței

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

29 dec. 2025, 06:30 UTC

Achiziții, Fuziuni, Preluări

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

21 mar. 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

Comparație

Modificare preț

DaVita Inc Așteptări

Obiectiv de preț

By TipRanks

28.92% sus

Prognoză pe 12 luni

Medie 136.5 USD  28.92%

Maxim 143 USD

Minim 130 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruDaVita Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

4 ratings

0

Cumpărare

3

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

142.36 / 144.275Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

30 / 352 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat